Literature DB >> 21123389

Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.

Yvonne Hofmeister1, Christina B Planitzer, Maria R Farcet, Wolfgang Teschner, H Arno Butterweck, Alfred Weber, Georg W Holzer, Thomas R Kreil.   

Abstract

West Nile virus (WNV)-neutralizing intravenous immune globulins (IVIG) were fractionated into IgG subclasses, and the contribution of each subclass to in vitro neutralization of and in vivo protection against WNV was evaluated. The results indicate that IgG1 (i) is the main subclass induced following WNV infection of humans, (ii) contained nearly all the in vitro WNV neutralization capacity, and (iii) mediates effector functions in vivo that render it superior to other subclasses in protection against WNV. The importance of human IgG1 indicates that a candidate WNV vaccine should induce an immune response that includes WNV-specific IgG1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123389      PMCID: PMC3028917          DOI: 10.1128/JVI.02155-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

Review 2.  Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists.

Authors:  F Dati; G Schumann; L Thomas; F Aguzzi; S Baudner; J Bienvenu; O Blaabjerg; S Blirup-Jensen; A Carlström; P H Petersen; A M Johnson; A Milford-Ward; R F Ritchie; P J Svendsen; J Whicher
Journal:  Eur J Clin Chem Clin Biochem       Date:  1996-06

3.  Single incubation multilayer immune technique.

Authors:  W L Naser
Journal:  J Immunol Methods       Date:  1990-05-25       Impact factor: 2.303

4.  Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.

Authors:  O Scharf; H Golding; L R King; N Eller; D Frazier; B Golding; D E Scott
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

Authors:  Otfried Kistner; Brian A Crowe; Walter Wodal; Astrid Kerschbaum; Helga Savidis-Dacho; Nicolas Sabarth; Falko G Falkner; Ines Mayerhofer; Wolfgang Mundt; Manfred Reiter; Leopold Grillberger; Christa Tauer; Michael Graninger; Alois Sachslehner; Michael Schwendinger; Peter Brühl; Thomas R Kreil; Hartmut J Ehrlich; P Noel Barrett
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

6.  Metabolic properties of IgG subclasses in man.

Authors:  A Morell; W D Terry; T A Waldmann
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

7.  Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.

Authors:  J J Schlesinger; S Chapman
Journal:  J Gen Virol       Date:  1995-01       Impact factor: 3.891

8.  The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.

Authors:  J J Schlesinger; M Foltzer; S Chapman
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

9.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Authors:  Theodore Oliphant; Michael Engle; Grant E Nybakken; Chris Doane; Syd Johnson; Ling Huang; Sergey Gorlatov; Erin Mehlhop; Anantha Marri; Kyung Min Chung; Gregory D Ebel; Laura D Kramer; Daved H Fremont; Michael S Diamond
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

Review 10.  Virology, pathology, and clinical manifestations of West Nile virus disease.

Authors:  Edward B Hayes; James J Sejvar; Sherif R Zaki; Robert S Lanciotti; Amy V Bode; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  18 in total

Review 1.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations.

Authors:  Philip O Rabel; Christina B Planitzer; Maria R Farcet; Thomas R Kreil
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

3.  Single-dose vaccine against tick-borne encephalitis.

Authors:  Alexander A Rumyantsev; Ana P Goncalvez; Maryann Giel-Moloney; John Catalan; Yuxi Liu; Qing-sheng Gao; Jeff Almond; Harry Kleanthous; Konstantin V Pugachev
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

4.  TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate.

Authors:  Jingya Xia; Evandro R Winkelmann; Summer R Gorder; Peter W Mason; Gregg N Milligan
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 5.  Expanding roles for CD4⁺ T cells in immunity to viruses.

Authors:  Susan L Swain; K Kai McKinstry; Tara M Strutt
Journal:  Nat Rev Immunol       Date:  2012-01-20       Impact factor: 53.106

Review 6.  The human antibody response to dengue virus infection.

Authors:  Wahala M P B Wahala; Aravinda M de Silva
Journal:  Viruses       Date:  2011-11-25       Impact factor: 5.048

7.  Lysosome-associated membrane glycoprotein (LAMP)--preliminary study on a hidden antigen target for vaccination against schistosomiasis.

Authors:  Sujeevi S K Nawaratna; Geoffrey N Gobert; Charlene Willis; Jason Mulvenna; Andreas Hofmann; Donald P McManus; Malcolm K Jones
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

Review 8.  Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies.

Authors:  Vittorio Sambri; Maria R Capobianchi; Francesca Cavrini; Rémi Charrel; Olivier Donoso-Mantke; Camille Escadafal; Leticia Franco; Paolo Gaibani; Ernest A Gould; Matthias Niedrig; Anna Papa; Anna Pierro; Giada Rossini; Andrea Sanchini; Antonio Tenorio; Stefania Varani; Ana Vázquez; Caterina Vocale; Herve Zeller
Journal:  Viruses       Date:  2013-09-25       Impact factor: 5.048

9.  HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses.

Authors:  Clare Burn Aschner; Lip Nam Loh; Benjamin Galen; Isabel Delwel; Rohit K Jangra; Scott J Garforth; Kartik Chandran; Steven Almo; William R Jacobs; Carl F Ware; Betsy C Herold
Journal:  Sci Immunol       Date:  2020-08-14

10.  Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.

Authors:  Rui-Yuan Cao; Da-Yong Dong; Rui-Ju Liu; Jian-Feng Han; Guang-Chuan Wang; Hui Zhao; Xiao-Feng Li; Yong-Qiang Deng; Shun-Ya Zhu; Xiao-Yu Wang; Fang Lin; Fu-Jun Zhang; Wei Chen; E-De Qin; Cheng-Feng Qin
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.